Antibody (Also Called An Immunoglobulin.)

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

(AFX UK Focus) 2010-02-09 16:54 UK court rules HGS gene patent invalid -lawyers

Published February 9, 2010, 9:11 am, Interactive Investor

LONDON, Feb 9 (Reuters) - A British court has upheld a ruling invalidating a patent on a gene sequence held by Human Genome Sciences, handing victory in the case to Eli Lilly which had challenged HGS's patent, lawyers familiar with the case said on Tuesday. The ruling could affect future decisions by UK courts on the scope of biotech patents, they said, and may also influence decisions in other ...

Discover News | Full Story


Prion Leaves Lasting Mark on Memory

Published February 9, 2010, 7:01 am, US News & World Report

Researchers suggest that a prion-like protein may participate in memory in higher eukaryotes.

Discover News | Full Story


Standard Needle Size Not Always Adequate For Obese Teens

Published February 9, 2010, 6:10 am, redOrbit

Researchers report in the Feb. 8 issue of the journal Pediatrics that using a standard 1-inch needle to immunize obese adolescents against hepatitis B virus produces a much weaker effect than using a longer needle.Amy B.

Discover News | Full Story


Press Release

Published February 9, 2010, 5:40 am, PharmiWeb

HIGH WYCOMBE, England, February 8 /PRNewswire/ -- STELARA (ustekinumab) has today been accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHS Scotland for the treatment of moderate to severe plaque psoriasis.(1) STELARA is the first in a novel class of biologics.

Discover News | Full Story


Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer

Published February 9, 2010, 5:00 am, Business Wire via Yahoo! Finance

MONROVIA, Calif.----Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today the appointment of Edgardo Baracchini, Ph.D., to chief business officer.

Discover News | Full Story


Biogen Idec reports 2009 fourth quarter and full year earnings

Published February 9, 2010, 4:46 am, News-Medical-Net

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2009 results.

Discover News | Full Story


Fourth-quarter and full-year 2009 results announced by Compugen

Published February 9, 2010, 4:46 am, News-Medical-Net

Compugen Ltd. today reported financial results for the fourth quarter and year ending December 31, 2009.

Discover News | Full Story


NOVAVAX Reports Additional Positive Data From Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study In Healthy ...

Published February 9, 2010, 4:21 am, Medical News Today

Novavax, Inc. (Nasdaq: NVAX) announced new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains...

Discover News | Full Story


GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For ...

Published February 9, 2010, 4:20 am, Medical News Today

GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) (the "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, provided an update on its vaccine trials progress. "The HIV/AIDS population continues to grow at an alarming rate, 60,000 new infections annually, and that's just in the United ...

Discover News | Full Story


Immunovaccine Presents Results For An Enhanced Anthrax Vaccine Candidate

Published February 9, 2010, 4:20 am, Medical News Today

Immunovaccine Inc. (TSX VENTURE:IMV) announced that it has been invited to present at the Canada - U.S. Partners in Biomedical Defense II Conference in Washington, D.C. on Wednesday, February 10, 2010. At the Conference the Company will present positive new research, done in collaboration with Defence Research and Development Canada (DRDC), confirming the number of required doses for an anthrax ...

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a